TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2023
Back to search
Official data from USPTO
ARC INNOVATION AT SHEBA MEDICAL CENTER
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
07/15/2023
Trademark type
Combined
Nice classes
35, 42
Filing date
02/16/2021
Registration date
10/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/04/2022
Last transaction
07/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
IL
Examiner
JOINER, KATINA
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of he letters ARC in a large, blue stylized font with a yellow dot in the center of the letter C. Beneath ARC is the stylized wording INNOVATION AT SHEBA MEDICAL CENTER in black.
Holders and representatives
Holders
The Sheba Fund for Health Services and Research (R.A)
Representatives
JACQUELINE ZION PEARL COHEN ZEDEK LATZER BARATZ LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Consultancy relating to the commercialization of medical products and technologies; business management of all types (commercialoperationdevelopment and marketing) of development centers and business incubators in the fields of medical products and technologies; commercialization of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposesveterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticalsanti-cancer preparationsbiological preparationsvaccine preparations
Class 42
Consultancy relating to the development of medical products and technologies; design and development of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposesveterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticalsanti-cancer preparationsbiological preparationsvaccine preparations
Publications
History of USPTO decisions and trademark events.
40 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/14/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/26/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
01/26/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/04/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/04/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
10/04/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
08/25/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/24/2022
APET
ASSIGNED TO PETITION STAFF
08/22/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
08/05/2022
CHPB
POST PUBLICATION AMENDMENT - ENTERED
05/10/2022
APET
ASSIGNED TO PETITION STAFF
05/10/2022
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
04/18/2022
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
03/14/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/15/2022
PUBO
PUBLISHED FOR OPPOSITION
02/15/2022
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/26/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/26/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
01/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
01/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/23/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2021
RFNT
REFUSAL PROCESSED BY IB
10/25/2021
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/27/2021
RFRR
REFUSAL PROCESSED BY MPU
09/27/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/12/2021
CNRT
NON-FINAL ACTION WRITTEN
09/11/2021
DOCK
ASSIGNED TO EXAMINER
09/11/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/21/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/15/2021
Continuous trademark protection
Get notified about every new filing that threatens ARC INNOVATION AT SHEBA MEDICAL CENTER or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.